Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

‘Celebrating the music of our times’
2013-07-25

 

25 July 2013

The Odeion School of Music’s (OSM) New Music Week, hosted from 17–20 July 2013, offered an experience of profundity.

This was the second week-long festival of its kind to be hosted by the OSM – last year the 90th birthday of the South African composer, Stefans Grové, was celebrated with concerts and a symposium. This year the New Music Week focused on the visit of Ensemble Trans-Z under the artistic leadership of former OSM student, Alfred Vorster, a composer living in Zürich. The Order of the Odeion School of Music was bestowed upon Vorster during the festival. The members of the ensemble are the Belgian pianist Lukas Huisman, Danré Strydom (currently an OSM doctoral student in clarinet, based in Ghent), the Argentinian violinist Juan Braceras and the Swedish cellist Karolina Öhman (both currently living in Basel, Switzerland).

The week included three lectures. Lukas Huisman elucidated his doctoral project, Alfred Vorster offered an analytical perspective on the work of Helmut Lachenmann and Hannes Taljaard (Potchefstroom) delivered a commentary on his own composition practice. In addition to presenting masters’ classes in their individual instruments, Ensemble Trans-Z also hosted two workshops – one for the Mangaung String Project and another for OSM students and staff. These workshops focused on creative improvisation practices within an avant-garde style.

The highlight of the festival was two gala concerts that were held on 19 and 20 July. The first concert was hosted by Ensemble Trans-Z themselves, with a selection of compositions in the avant-garde style. The programme included challenging listening material and was creatively presented with unconventional lighting techniques and visual material.

The concert on 20 July consisted of New Music of a more conventional nature. The Odeion String Quartet offered a varied presentation which consisted of a rich mix of talent. OSM postgraduate students Marianne Cilliers, Karol Legierski and Eljee du Plooy formed part of this spectacular performance. The OSM flute lecturer, Handri Loots and the members of Ensemble Trans-Z supplied additional depth to the concert. The experience was made extra special by the recently-formed New Music Ensemble of the School of Music at the North-West University – led by Augusto Arias. Under conductorship of Jan-Moritz Onken, the OSM Camerata completed this impressive collaboration.

The Camerata’s recital of Hendrik Hofmeyr’s Phantom Waltz, which the composer newly arranged especially for this ensemble, was but one of the artistic highlights of an inspiring presentation.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept